Quantcast

Beacon Equity Research Clients

Below you will find a list of Beacon Equity Research's clients.
Click on the client's name to view information on that specific client.

QualityStocks Partner Clients

SmallCapVoice Clients
Stock Guru Clients

 


Untitled Document

Generex Biotechnology Corp. (GNBT)

Generex Biotechnology Corp. (GNBT) is a drug research and development company whose expertise is finding innovative and commercialized ways to administer drugs throughout the human body. The company has developed a platform technology for the delivery of drugs via the oral cavity.

To meet the demands of this type of drug administration, Generex developed its RapidMist™ device so that the drugs typically administered by injection can be absorbed into the body by the lining of the inner mouth. Combined with Generex's proprietary liquid drug formulations, the company is able to achieve its goal of innovative drug administration.

Generex's flagship product, oral insulin (Generex Oral-lyn™), is in various stages of clinical development around the world. The company announced that the global Phase III clinical trial of Generex Oral-lyn™ has commenced in the USA, Canada, Russia, The Ukraine, Romania, Bulgaria and Poland. The product is currently available for sale in Ecuador for the treatment of patients with Type-1 and Type-2 diabetes and was approved for sale in India in October 2007.

Generex also has a wholly owned subsidiary, Antigen Express, Inc., which uses immunotherapeutics for the treatment of malignant, infectious, allergic, and autoimmune diseases.

Beacon Equity Research Blog

Generex Biotechnology Corp. Message Board

 

The QualityStocks
Newsroom

Read the articles covering the biggest movers in the markets today.

Continue

Market
Basics

Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks markets.

Continue

The QualityStocks Daily
Archives

Go back to see our previous newsletters and find out what you might have missed.

Continue